CJC-1295 + Ipamorelin 10mg

This blend combines CJC-1295 (a GHRH analogue) with Ipamorelin (a selective ghrelin/GH secretagogue) in one vial. The combination is used in research to study two complementary pathways involved in growth hormone release side by side.

Research context

In research, CJC-1295 targets the GHRH receptor, while Ipamorelin acts on the ghrelin receptor. Together they form a study compound within research on growth hormone signalling. Intended for research use only.

Specifications

Compound: CJC-1295 (no DAC) + Ipamorelin blend

Contents: 10 mg total per vial

Form: lyophilised white powder

Purity: >99% per component (HPLC verified)

Includes: 3ml BAC water and 4 injection needles supplied free with every order

Storage & reconstitution

Store lyophilised, cool and dark; long-term at −20 °C. After reconstitution, store refrigerated and use within the usual research timeframe. Determine the volume with our calculator.

Quality

Independently tested per batch; the Certificate of Analysis (COA) is available on our COA page.

Disclaimer

For laboratory and research use only. Not for human or animal consumption.